American Society For Transplantation And Cellular Therapy | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Headlines Articles Press releases American Society For Transplantation And Cellular Therapy

Home
Companies
American Society For Transplantation And Cellular Therapy

BRIEF

published on 11/11/2024 at 18:05, 9 days 16 hours ago

2025 Tandem Meetings to Convene Experts in Hawai'i

Tandem Meetings Hematopoietic Cell Transplantation Medical Advancements Cellular And Gene Therapy ASTCT And CIBMTR
PRESS RELEASE

published on 11/11/2024 at 18:00, 9 days 16 hours ago

The Tandem Meetings of ASTCT and CIBMTR Return to Hawai'i From February 12-15, 2025
ASTCT and CIBMTR unite leading experts at the Tandem Meetings to share advancements in HCT, cellular therapy, and gene therapy with a global community of professionals. Event highlights latest scientific updates and innovative technologies

Cellular Therapy Gene Therapy Tandem Meetings HCT Scientific Updates
BRIEF

published on 08/15/2024 at 19:05, 3 months 5 days ago

FDA Approves Axatilimab-Csfr for Chronic Graft-Versus-Host Disease

FDA Approval ASTCT Axatilimab-csfr CGVHD Treatment AGAVE-201 Study
PRESS RELEASE

published on 08/15/2024 at 19:00, 3 months 5 days ago

ASTCT Applauds FDA Approval of Axatilimab-Csfr for the Treatment of Chronic Graft-Versus-Host Disease (cGVHD)
ASTCT applauds FDA approval of Niktimvo by Incyte Corporation for cGVHD treatment. Study confirms efficacy and potential benefits for patients. ASTCT remains committed to advancing transplantation field

FDA Approval ASTCT Transplantation CGVHD Treatment Niktimvo
BRIEF

published on 08/02/2024 at 22:15, 3 months 18 days ago

FDA Approves TECELRA for Synovial Sarcoma Treatment

FDA Approval Cellular Therapy ASTCT Synovial Sarcoma TECELRA
PRESS RELEASE

published on 08/02/2024 at 22:10, 3 months 18 days ago

American Society for Transplantation and Cellular Therapy Applauds FDA Approval of TECELRA(R) for Synovial Sarcoma Treatment
The FDA's accelerated approval of TECELRA marks a milestone in cancer treatment. ASTCT supports this advance in cellular therapy for synovial sarcoma patients

FDA Approval Cellular Therapy ASTCT Synovial Sarcoma TECELRA
BRIEF

published on 04/10/2024 at 16:05, 7 months 10 days ago

ASTCT Endorses FDA's New CAR T-Cell Therapy Approvals for Multiple Myeloma

FDA Approval Medical Innovation Multiple Myeloma CAR T-cell Therapy ASTCT Endorsement
PRESS RELEASE

published on 04/10/2024 at 16:00, 7 months 10 days ago

ASTCT Supports the FDA's Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma
FDA approves expanded use of CAR T-Cell therapies Abecma and Carvykti for multiple myeloma treatment, supported by ASTCT. Decision based on FDA and ODAC recommendations

FDA Approval Multiple Myeloma CAR T-cell Therapy ASTCT Support Disease Intervention
BRIEF

published on 03/22/2024 at 16:05, 7 months 29 days ago

Medicare Expands Stem Cell Transplant Coverage for Myelodysplastic Syndromes

Medicare Stem Cell Transplantation Health Policy Myelodysplastic Syndromes National Coverage Determination
PRESS RELEASE

published on 03/22/2024 at 16:00, 7 months 29 days ago

The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation
CMS revises National Coverage Determination for allogeneic HSCT in MDS patients following requests from ASH, ASTCT, NMDP, and CIBMTR. Updated ruling expands Medicare coverage for life-saving treatment

National Coverage Determination CMS Allogeneic HSCT MDS Patients Medicare Coverage

Accesswire

Published on 11/21/2024 at 10:03, 43 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 46 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 46 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 11 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 21 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 16 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 41 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 44 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 46 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 46 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 48 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 26 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE